Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

QJM: An International Journal of Medicine

Volumn 107, Issue 8, 2014, Pages 613-621

  Orenes pinero E ^a   Hernandez Romero D ^a   Romero aniorte, A I ^a   Martinez M ^b   Garcia Honrubia A ^c   Caballero, L ^a   Garrigos Gomez N ^d   Andreu Cayuelas, J M ^a   Gonzalez J ^a   Feliu, E ^b   Climent, V ^b   Nicolas Ruiz F ^e   de la morena, G ^a   Valdes M ^a   Lip, G Y H ^f   Marin F ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^d Centro Inmunológico de Alicante CIALAB   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; GADOLINIUM; ALDOSTERONE SYNTHASE; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ALLELE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COL1A1 GENE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYP11B2 GENE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; AGED; ATRIAL FIBRILLATION; BLOOD; CASE CONTROL STUDY; COMPLICATION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALDOSTERONE; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; COLLAGEN TYPE I; CYTOCHROME P-450 CYP11B2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84904915990     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu046     Document Type: Article

References (29)

1. Pedrosa RP, Drager LF, Genta PR, Amaro AC, Antunes MO, Matsumoto AY, et al. Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest 2010; 137:1078-84.
2. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004; 363:1881-91.
3. Kaufman BD, Auerbach S, Reddy S, Manlhiot C, Deng L, Prakash A, et al. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum Genet 2007; 122:515-23.
4. Ortlepp JR, Vosberg HP, Reith S, Ohme F, Mahon NG, Schröder D, et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 2002; 87:270-5.
5. Perkins MJ, Van Driest SL, Ellsworth EG, Will ML, Gersh BJ, Ommen SR, et al. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J 2005; 26:2457-62.
6. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994; 331:250-8.
7. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, et al. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 1991; 5:1513-22.
8. Challa AA, Vukmirovic M, Blackmon J, Stefanovic B. Withaferin-a reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo. PLoS One 2012; 7:e42989.
9. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996; 14:203-5.
10. Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001; 88:275-9.
11. Wolf P, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22:983-8.
12. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997; 77:130-2.
13. Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, et al. Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2007; 60:15-23.
14. Bogaert J, Taylor AM, Van Kerkhove F, Dymarkowski S. Use of inversion recovery contrast-enhanced MRI for cardiac imaging: spectrum of applications. Am J Roentgenol 2004; 182:609-15.
15. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105:5439-42.
16. Stella P, Bigatti G, Tizzoni L, Barlassina C, Lanzani C, Bianchi G, et al. Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J Am Coll Cardiol 2004; 43:265-70.
17. Amir O, Amir RE, Paz H, Mor R, Sagiv M, Lewis BS. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol 2008; 102:326-9.
18. Weber KT, Brilla CG, Campbell SE, Guarda E, Zhou G, Sriram K. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol 1993; 88:107-24.
19. Belenkov YN, Privalova EV, Kaplunova VY, Stambol'skii DV, Fomin AA. Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy. Kardiologiia 2010; 50:27-34.
20. Yoshida Y, Morimoto T, Takaya T, Kawamura T, Sunagawa Y, Wada H, et al. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes. Circ J 2010; 74:156-62.
21. Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, et al. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 2004; 109:1284-91.
22. Tsai CT, Chiang FT, Tseng CD, Hwang JJ, Kuo KT, Wu CK, et al. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. J Am Coll Cardiol 2010; 55:758-70.
23. Zhao J, Li J, Li W, Li Y, Shan H, Gong Y, et al. Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol 2010; 159:1584-94.
24. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11:856-60.
25. Orenes-Piñero E, Hernández-Romero D, Jover E, Valdés M, Lip GY, Marín F. Impact of polymorphisms in the reninangiotensin-aldosterone system on hypertrophic cardiomyopathy. J Renin Angiotensin Aldosterone Syst 2011; 12:521-30.
26. Lala DS, Rice DA, Parker KL. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 1992; 6:1249-58.
27. Orenes-Piñero E, Montoro-García S, Banerjee A, Valdés M, Lip GY, Marín F. Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery. Mini Rev Med Chem 2012; 12:1419-31.
28. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92:1954-68.
29. Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens 2004; 22:1895-901.